Current progress of pig models for liver cancer research.

[1]  S. Chan,et al.  The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment , 2023, Clinical and molecular hepatology.

[2]  Haibo Hu,et al.  Advances in chimeric antigen receptor T cells therapy in the treatment of breast cancer. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  J. Ferlay,et al.  Global burden of primary liver cancer in 2020 and predictions to 2040 , 2022, Journal of hepatology.

[4]  Haixiang Yu,et al.  CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment , 2022, Frontiers in Immunology.

[5]  W. Lau,et al.  A novel Peng's test in reducing bile leakage after partial hepatectomy for hepatocellular carcinoma: From an animal study to a clinical cohort Propensity score matching comparative study. , 2022, International journal of surgery.

[6]  A. Mega,et al.  Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC , 2022, Cancers.

[7]  B. Griffith,et al.  Genetically Modified Porcine-to-Human Cardiac Xenotransplantation. , 2022, The New England journal of medicine.

[8]  V. Band,et al.  Large Animal Models of Breast Cancer , 2022, Frontiers in Oncology.

[9]  Ziyi Li,et al.  The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems , 2022, Frontiers in Oncology.

[10]  Uasim H. Harkus,et al.  Immune checkpoint inhibitors in HCC: cellular, molecular and systemic data. , 2022, Seminars in cancer biology.

[11]  S. Wells,et al.  Advanced CT techniques for hepatic microwave ablation zone monitoring and follow-up , 2021, Abdominal Radiology.

[12]  C. Tuggle,et al.  Swine models for translational oncological research: an evolving landscape and regulatory considerations , 2021, Mammalian Genome.

[13]  J. Calderaro,et al.  Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas. , 2021, European journal of medical genetics.

[14]  C. Dehelean,et al.  Experimental Models of Hepatocellular Carcinoma—A Preclinical Perspective , 2021, Cancers.

[15]  L. Spate,et al.  Cardiovascular Development and Congenital Heart Disease Modeling in the Pig , 2021, Journal of the American Heart Association.

[16]  S. Menne,et al.  Application of the woodchuck animal model for the treatment of hepatitis B virus-induced liver cancer , 2021, World journal of gastrointestinal oncology.

[17]  K. Schachtschneider,et al.  Transcriptional Profiling of Porcine HCC Xenografts Provides Insights Into Tumor Cell Microenvironment Signaling , 2021, Frontiers in Genetics.

[18]  J. Ji,et al.  Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE , 2021, European Radiology.

[19]  T. Hibi,et al.  Development of human hepatocellular carcinoma in X-linked severe combined immunodeficient pigs: An orthotopic xenograft model , 2021, PloS one.

[20]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[21]  K. Schachtschneider,et al.  Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model. , 2021, Biochimie.

[22]  K. Schachtschneider,et al.  Generation of genetically tailored porcine liver cancer cells by CRISPR/Cas9 editing , 2020, BioTechniques.

[23]  W. Xu,et al.  Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer , 2020, International journal of medical sciences.

[24]  A. Dubart-Kupperschmitt,et al.  Liver Regeneration and Recanalization Time Course following Repeated Reversible Portal Vein Embolization in Swine , 2020, European Surgical Research.

[25]  K. Lehmann,et al.  Influence of interapplicator distance on multibipolar radiofrequency ablation during physiological and interrupted liver perfusion in an in vivo porcine model , 2020, Scientific Reports.

[26]  K. Ono,et al.  Single-dose toxicity study by intra-arterial injection of 10BSH entrapped water-in-oil-in-water emulsion for boron neutron capture therapy to hepatocellular carcinoma. , 2020, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[27]  L. Rund,et al.  Development and comprehensive characterization of porcine hepatocellular carcinoma for translational liver cancer investigation , 2020, Oncotarget.

[28]  B. Goh,et al.  Safety, pharmacokinetics and tissue penetration of PIPAC paclitaxel in a swine model. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[29]  Yan Zhao,et al.  Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[30]  Julin Xie,et al.  Porcine acellular dermal matrix accelerates wound healing through miR-124-3p.1 and miR-139-5p. , 2020, Cytotherapy.

[31]  R. Pabst.  The pig as a model for immunology research , 2020, Cell and Tissue Research.

[32]  M. Hussein,et al.  Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities , 2020, International journal of nanomedicine.

[33]  J. Dekkers,et al.  Novel Engraftment and T Cell Differentiation of Human Hematopoietic Cells in ART−/− IL2RG−/Y SCID Pigs , 2020, Frontiers in Immunology.

[34]  R. Davalos,et al.  High-Frequency Irreversible Electroporation for Treatment of Primary Liver Cancer: A Proof-of-Principle Study in Canine Hepatocellular Carcinoma. , 2020, Journal of vascular and interventional radiology : JVIR.

[35]  H. Favoreel,et al.  Identification of a Porcine Liver EomeshighT-betlow NK Cell Subset That Resembles Human Liver Resident NK Cells , 2019, Front. Immunol..

[36]  J. Modiano,et al.  Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy , 2019, Journal of clinical medicine.

[37]  R. Duran,et al.  Vandetanib-eluting Radiopaque Beads: Pharmacokinetics, Safety, and Efficacy in a Rabbit Model of Liver Cancer. , 2019, Radiology.

[38]  T. Decaens,et al.  Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment , 2019, Cancers.

[39]  V. Longo,et al.  Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib , 2019, Medicina.

[40]  C. Fondevila,et al.  A novel and simple formula to predict liver mass in porcine experimental models , 2019, Scientific Reports.

[41]  E. Hatano,et al.  Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study , 2019, BMC Cancer.

[42]  A. Bleich,et al.  Porcine model for the study of liver regeneration enhanced by non-invasive 13C-methacetin breath test (LiMAx test) and permanent portal venous access , 2019, PloS one.

[43]  H. Mischinger,et al.  Diethylnitrosamine (DENA) recapitulates formation of hepatic angiosarcoma in pigs , 2019, PloS one.

[44]  M. Gorrell,et al.  Animal models for hepatocellular carcinoma. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[45]  Zaina T. Al-Salama,et al.  Lenvatinib: A Review in Hepatocellular Carcinoma , 2019, Drugs.

[46]  X. Ye,et al.  Experimental study in vivo ablation of swine pancreas using high-intensity focused ultrasound , 2019, Journal of cancer research and therapeutics.

[47]  I. Vignon-Clementel,et al.  Kinetics of Hepatic Volume Evolution and Architectural Changes after Major Resection in a Porcine Model , 2019, European Surgical Research.

[48]  C. Tuggle,et al.  Human Ovarian Cancer Tumor Formation in Severe Combined Immunodeficient (SCID) Pigs , 2019, Front. Oncol..

[49]  F. Godtliebsen,et al.  The effects of terlipressin and direct portacaval shunting on liver hemodynamics following 80% hepatectomy in the pig , 2019, Clinical science.

[50]  Li Wang,et al.  Gamma linolenic acid regulates PHD2 mediated hypoxia and mitochondrial apoptosis in DEN induced hepatocellular carcinoma , 2018, Drug design, development and therapy.

[51]  C. Tuggle,et al.  Development of Severe Combined Immunodeficient (SCID) Pig Models for Translational Cancer Modeling: Future Insights on How Humanized SCID Pigs Can Improve Preclinical Cancer Research , 2018, Front. Oncol..

[52]  X. Yi,et al.  Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study , 2018, Clinical Cancer Research.

[53]  S. Curley,et al.  Improved, Shorter-Latency Carcinogen-Induced Hepatocellular Carcinoma Model in Pigs , 2018, Oncology.

[54]  H. Lennernäs,et al.  Porcine and Human In Vivo Simulations for Doxorubicin-Containing Formulations Used in Locoregional Hepatocellular Carcinoma Treatment , 2018, The AAPS Journal.

[55]  S. Weber,et al.  Multi-Operational Selective Computer-Assisted Targeting of hepatocellular carcinoma—Evaluation of a novel approach for navigated tumor ablation , 2018, PloS one.

[56]  L. Leija,et al.  Feasibility of Using a Novel 2.45 GHz Double Short Distance Slot Coaxial Antenna for Minimally Invasive Cancer Breast Microwave Ablation Therapy: Computational Model, Phantom, and In Vivo Swine Experimentation , 2018, Journal of healthcare engineering.

[57]  Shihua Li,et al.  A Huntingtin Knockin Pig Model Recapitulates Features of Selective Neurodegeneration in Huntington’s Disease , 2018, Cell.

[58]  D. Eckhoff,et al.  Xenotransplantation-the current status and prospects. , 2018, British medical bulletin.

[59]  Tim F. Rayner,et al.  Mutational landscape of a chemically-induced mouse model of liver cancer , 2018, bioRxiv.

[60]  Hong-xia Yu,et al.  Capsaicin enhances the antitumor activity of sorafenib in hepatocellular carcinoma cells and mouse xenograft tumors through increased ERK signaling , 2017, Acta Pharmacologica Sinica.

[61]  O. Nureki,et al.  Production and rearing of germ-free X-SCID pigs , 2017, Experimental animals.

[62]  L. Rund,et al.  A validated, transitional and translational porcine model of hepatocellular carcinoma , 2017, Oncotarget.

[63]  Zhen Xu,et al.  Non-Invasive Liver Ablation Using Histotripsy: Preclinical Safety Study in an In Vivo Porcine Model. , 2017, Ultrasound in medicine & biology.

[64]  Lei Chen,et al.  New knowledge of the mechanisms of sorafenib resistance in liver cancer , 2017, Acta Pharmacologica Sinica.

[65]  J. Ryu,et al.  Biallelic modification of IL2RG leads to severe combined immunodeficiency in pigs , 2016, Reproductive Biology and Endocrinology.

[66]  H. Uenishi,et al.  Generation and characterization of RAG2 knockout pigs as animal model for severe combined immunodeficiency. , 2016, Veterinary immunology and immunopathology.

[67]  M. Hauer-Jensen,et al.  Minipigs as models in drug discovery , 2016, Expert opinion on drug discovery.

[68]  Jeffrey S. Morris,et al.  Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs , 2016, Oncology.

[69]  Lijuan Yuan,et al.  Increased and prolonged human norovirus infection in RAG2/IL2RG deficient gnotobiotic pigs with severe combined immunodeficiency , 2016, Scientific Reports.

[70]  J. Bruix,et al.  Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. , 2016, Gastroenterology.

[71]  M. Groenen.  A decade of pig genome sequencing: a window on pig domestication and evolution , 2016, Genetics Selection Evolution.

[72]  C. London,et al.  Dogs as a Model for Cancer. , 2016, Annual review of animal biosciences.

[73]  F. Sánchez-Margallo,et al.  Common swine models of cardiovascular disease for research and training , 2016, Lab Animal.

[74]  J. Dekkers,et al.  Not All SCID Pigs Are Created Equally: Two Independent Mutations in the Artemis Gene Cause SCID in Pigs , 2015, The Journal of Immunology.

[75]  R. Prather,et al.  A Genetic Porcine Model of Cancer , 2015, PloS one.

[76]  N. Gibran,et al.  Porcine models of cutaneous wound healing. , 2015, ILAR journal.

[77]  Chengxiang Li,et al.  Preclinical Study of Locoregional Therapy of Hepatocellular Carcinoma by Bioelectric Ablation with Microsecond Pulsed Electric Fields (μsPEFs) , 2015, Scientific Reports.

[78]  William D Hopkins,et al.  Why primate models matter , 2014, American journal of primatology.

[79]  A. Schambach,et al.  RAG1/2 Knockout Pigs with Severe Combined Immunodeficiency , 2014, The Journal of Immunology.

[80]  R. Gaba,et al.  Development, growth, propagation, and angiographic utilization of the rabbit VX2 model of liver cancer: a pictorial primer and "how to" guide. , 2014, Diagnostic and interventional radiology.

[81]  Jeeyoung Kim,et al.  Generation of liver-specific TGF-α and c-Myc-overexpressing fibroblasts for future creation of a liver cancer porcine model. , 2014, Molecular medicine reports.

[82]  R. Roberts,et al.  Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency , 2014, Proceedings of the National Academy of Sciences.

[83]  Y. Hanazono,et al.  Generation of Interleukin-2 Receptor Gamma Gene Knockout Pigs from Somatic Cells Genetically Modified by Zinc Finger Nuclease-Encoding mRNA , 2013, PloS one.

[84]  H. Schubert,et al.  Lung flooding enables efficient lung sonography and tumour imaging in human ex vivo and porcine in vivo lung cancer model , 2013, European Journal of Medical Research.

[85]  M. Swindle,et al.  Best Practices for Performing Experimental Surgery in Swine , 2013, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[86]  E. Wagner,et al.  Mouse models for liver cancer , 2013, Molecular oncology.

[87]  Jinjun Li,et al.  Establishment of NOD/SCID mouse models of human hepatocellular carcinoma via subcutaneous transplantation of histologically intact tumor tissue. , 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[88]  J. Geschwind,et al.  Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma? , 2013, Radiology.

[89]  J. Dekkers,et al.  Preliminary Findings of a Previously Unrecognized Porcine Primary Immunodeficiency Disorder , 2013, Veterinary pathology.

[90]  E. Wolf,et al.  A porcine model of familial adenomatous polyposis. , 2012, Gastroenterology.

[91]  Bronwen L. Aken,et al.  Analyses of pig genomes provide insight into porcine demography and evolution , 2012, Nature.

[92]  Zhen Xu,et al.  Image-guided non-invasive ultrasound liver ablation using histotripsy: Feasibility study in an in vivo porcine model , 2012, 2012 IEEE International Ultrasonics Symposium.

[93]  Y. Kashiwakura,et al.  Il2rg gene-targeted severe combined immunodeficiency pigs. , 2012, Cell stem cell.

[94]  Matthew T. Basel,et al.  Human Xenografts Are Not Rejected in a Naturally Occurring Immunodeficient Porcine Line: A Human Tumor Model in Pigs , 2012, BioResearch open access.

[95]  D. Bar-Sagi,et al.  RAS oncogenes: weaving a tumorigenic web , 2011, Nature Reviews Cancer.

[96]  Dong Chen,et al.  In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. , 2010, ACS nano.

[97]  N. Chalasani,et al.  Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine , 2009, Hepatology.

[98]  D. Kerr,et al.  A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma , 2009, Hepatology.

[99]  David K. Meyerholz,et al.  Disruption of the CFTR Gene Produces a Model of Cystic Fibrosis in Newborn Pigs , 2008, Science.

[100]  A. Suzuki,et al.  Non‐alcoholic steatohepatitis and hepatocellular carcinoma: Lessons from hepatocyte‐specific phosphatase and tensin homolog (PTEN)‐deficient mice , 2007, Journal of Gastroenterology and Hepatology.

[101]  K. Kotoh,et al.  Decreased portal flow volume increases the area of necrosis caused by radio frequency ablation in pigs , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[102]  J. Zachary,et al.  Genetic induction of tumorigenesis in Swine , 2007, Oncogene.

[103]  A. Ribas,et al.  A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides , 2006, Clinical Cancer Research.

[104]  K. Hong,et al.  New Intra-arterial Drug Delivery System for the Treatment of Liver Cancer: Preclinical Assessment in a Rabbit Model of Liver Cancer , 2006, Clinical Cancer Research.

[105]  D. Scutt,et al.  N-Nitrosodiethylamine-Induced Pig Liver Hepatocellular Carcinoma Model: Radiological and Histopathological Studies , 2006, CardioVascular and Interventional Radiology.

[106]  Jaume Bertranpetit,et al.  Comparative analysis of cancer genes in the human and chimpanzee genomes , 2006, BMC Genomics.

[107]  Wei Li,et al.  Pigs in sequence space: A 0.66X coverage pig genome survey based on shotgun sequencing , 2005, BMC Genomics.

[108]  P. Flecknell,et al.  Creation of porcine liver tumour using human hepatoma cell lines: Experimental study , 2005, Cancer biology & therapy.

[109]  Elkan F Halpern,et al.  Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. , 2004, JAMA.

[110]  Shu-sen Zheng,et al.  A modified rat model for hepatocellular carcinoma. , 2004, Hepatobiliary & pancreatic diseases international : HBPD INT.

[111]  S. Thorgeirsson,et al.  Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice. , 2004, Gastroenterology.

[112]  M. Buendia,et al.  Integration of woodchuck hepatitis and N‐myc rearrangement determine size and histologic grade of hepatic tumors , 2004, Hepatology.

[113]  L. Kèlland,et al.  Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. , 2004, European journal of cancer.

[114]  M. Taketo,et al.  Hepatocarcinogenesis in Mice with β-Catenin and Ha-Ras Gene Mutations , 2004, Cancer Research.

[115]  D. Malkin.  Li-fraumeni syndrome. , 2001, Genes & cancer.

[116]  M. Buendia,et al.  Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[117]  T. Kararli.  Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.

[118]  L. Lumeng,et al.  A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation. , 1992, The Journal of surgical research.

[119]  J. Graw,et al.  Hepatocarcinogenetic effect of DENA in pigs , 1977, Zeitschrift für Krebsforschung und Klinische Onkologie.

[120]  M. Rajewsky,et al.  Liver Carcinogenesis by Diethylnitrosamine in the Rat , 1966, Science.

[121]  Tao Li,et al.  Daphnetin Ameliorates the Expansion of Chemically Induced Hepatocellular Carcinoma via Reduction of Inflammation and Oxidative Stress. , 2022, Journal of oleo science.

[122]  Mardas Daneshian,et al.  Critical evaluation of the use of dogs in biomedical research and testing in Europe. , 2011, ALTEX.

[123]  S. Thorgeirsson,et al.  Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. , 1993, Cancer research.

[124]  M. Swindle,et al.  Swine as models in experimental surgery. , 1988, Journal of investigative surgery : the official journal of the Academy of Surgical Research.